Karen Dickinson, 57, was at an appointment about her knee when the osteopath noticed a mole on her lower back which tests ...

Despite familiarity with cognitive screening and its benefits, current and emerging screening and testing tools for Alzheimer’s disease and related dementias remain vastly underused, according to ...

The past decade has seen a dramatic increase in the technology that allows the detection of minute amounts of disease-related analytes in biofluids. This is ...

Biomarker testing has the potential to improve patient outcomes significantly, but its high cost means it's not accessible to everyone.

Biomarker testing has the potential to improve patient outcomes significantly, but its high cost means it's not accessible to everyone.

Kettering, is hoping the third time's the charm on her effort to require private insurers to cover "biomarker" medical testing and thereby improve health outcomes in Ohio and cut down on personal ...

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

Despite the potential benefits of early detection and increasing treatment options for Alzheimer’s disease and related dementias, there is limited use of valuable screening and testing tools, say ...

Study highlights concerns about premature adoption of preeclampsia screening tests, emphasizing the need for clinical utility trials before widespread implementation.

Now, several publications and presentations at the recent Alzheimer’s Association International Conference have demonstrated that blood tests measuring amyloid and tau proteins have become much more ...

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...